A British coroner has concluded that the death of Lady Joan Branson, wife of billionaire Richard Branson, might have been avoided with proper medical intervention. Following a fall on Necker Island, the 80-year-old was hospitalized in November 2025, where a lack of blood-thinning medication contributed to a fatal pulmonary embolism.
The role of enoxaparin in Lady Branson's fatal embolism
Senior coroner Fiona Wilcox told the Westminster Coroner's Court that Lady Joan Branson's death was likely preventable. The inquest revealed that the 80-year-old suffered a pulmonary embolism caused by deep vein thrombosis (DVT), a condition where blood clots travel to the lungs and block an artery. According to The Independent, Wilcox noted that the lack of anticoagulation—specifically the injectable blood thinner enoxaparin—likely contributed to the fatal outcome.
Lady Branson’s medical vulnerability increased significantly following a fall on Necker Island, the British Virgin Islands estate owned by her husband.. The fall resulted in a fracture that led to prolonged immobility, a primary risk factor for the development of dangerous blood clots in hospitalized patients.
Dr. Kunduzi's failure to perform a bleeding risk assessment
During the legal inquest, testimony from medical staff highlighted significant gaps in the patient's care protocol. Dr. Basir Kunduzi testified that he did not complete a formal bleeding risk assessment on the day of Lady Branson's admission to the hospital. This assessment is a critical step in determining whether a patient can safely receive anticoagulants.
As reported by the BBC, Dr... Kunduzi stated that the circumstances of Lady Branson's death led him to reflect on his professional role and the vital necessity of maintaining clear communication between medical team members. The omission of the assessment meant that the medical team may have been operating without a clear understanding of whether the risk of bleeding outweighed the risk of clotting.
The medical debate over enoxaparin's risk-to-benefit ratio
The inquest brought to light a recurring tension in clinical settings: the balance between preventing clots and the danger of internal bleeding. While doctors provided differing testimony regarding whether Lady Branson's speicfic bleeding risk justified withholding medication, the broader medical consensus remains clear. Dr. Jared Ross, an emergency medicine physician, told Fox News Digital that in the vast majority of cases, the benefits of blood-thinning medication outweigh the risks for hospitalized adults.
Medical experts note that nearly all hospitalized patients,particularly those suffering from fractures or undergoing prolonged bed rest, should receive some form of prevention. This can include pharmacological interventions like enoxaparin or mechanical devices designed to maintain blood flow in the legs.
Who made the final call to withhold blood thinners?
Despite the coroner's findings,several critical details regarding the clinical decision-making process remain unverified. While the inquest established that the lack of medication was a contributing factor, it did not explicitly identfiy which specific individual or group of clinicians made the final decision to withhold anticoagulants . It remains unclear if the decision was a result of a systemic failure in hospital protocol or an isolated error in judgment.
Furthermore, the source does not clarify whether the medical team had documented concerns about Lady Branson's specific bleeding risks prior to her death. Without a clear record of the rationale used by the attending physicians, the exact cause of the decision to bypass standard preventative care remains an open question.
Comments 0